C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/538 (2006.01) A61P 11/06 (2006.01)
Patent
CA 2697495
The present invention relates to the xinafoate salt of N4-[(2,2-difluoro-4H- benzo[1,4]oxazin-3-one)-6-yl]-5-flu- oro-N2-[3-(methylaminocarbonylmethylene oxy)phenyl]-2,4-pyrimidinediamine. This compound is a suitable drug substance and is useful in the treatment of conditions including asthma.
La présente invention porte sur le sel de xinafoate de N4-[(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(méthylaminocarbonylméthylène oxy) phényl-2,4-pyrimidinediamine. Ce composé est une substance médicamenteuse appropriée et est utile dans le traitement d'états comprenant l'asthme.
Limited Pfizer
Rigel Pharmaceuticals Inc.
Torys Llp
LandOfFree
Salt form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salt form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salt form will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1993457